FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to novel solid forms of N-(4-(7-azabicyclo[2,2,1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide (A-HCl forms, B forms, B-HCl forms). The invention also relates to pharmaceutical compositions based on A-HCl forms, or B forms, or B-HCl forms, or combinations thereof; a method of treating diseases caused by CFTR mutations; a method of modulating CFTR activity in a biological sample.
EFFECT: obtaining novel stable solid forms of N-(4-(7-azabicyclo[2,2,1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, having biological activity.
32 cl, 24 dwg, 13 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID FORMS OF N-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL-)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUIINOLINE-3-CARBOXAMIDE | 2009 |
|
RU2518479C2 |
METHOD FOR OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2553989C2 |
3-CARBOXAMIDE-4-OXOQUINOLINE DERIVATIVES, USEFUL AS MODULATORS OF REGULATOR OF TRANSMEMBRANE CYSTIC FIBROSIS CONDUCTIVITY | 2010 |
|
RU2518897C2 |
CO-CRYSTALS OF TRANSMEMBRANE CONDUCTION REGULATOR MODULATORS IN CYSTIC FIBROSIS | 2015 |
|
RU2749213C2 |
SOLID FORMS OF 3-(2, 2-DIFLUOROBENZO[D][1,3] DIOXOL-5-YL)CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID | 2011 |
|
RU2579370C2 |
METHOD OF OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2543714C2 |
SILICON-CONTAINING IVACAFTOR ANALOGUES | 2017 |
|
RU2796112C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY A TRANSMEMBRANE REGULATOR OF CYSTIC FIBROSIS (CFTR) | 2013 |
|
RU2692676C2 |
METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING CFTR MEDIATED DISEASES | 2014 |
|
RU2718044C2 |
SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE | 2011 |
|
RU2573830C2 |
Authors
Dates
2015-11-20—Published
2010-10-21—Filed